GTLL - Comprehensive Filing Intelligence

Q2 2026•10-Q•Filed Feb 20, 2026
3.0/10
Filing Health:CONCERN

Significant issues identified across multiple dimensions

Executive Summary

The company has terminated its acquisition of GOe3, reallocating resources to its core health technology and advisory services businesses.. Revenue decrease due to strategic shift in Primecare Supply.

Top Concerns

  • !Operating cash flow has turned negative, indicating a weakening in core operational cash generation, with a significant portion of net income offset by non-operational gains and other items.
  • !Significant negative operating cash flow despite positive net income, driven by a large gain on derivative liability.
  • !Capital Structure Risk (high)
  • !Internal Control Weaknesses (medium)

Top Positives

  • +The company is undergoing a strategic shift from a wholesale to a direct-to-clinic sales model, which is impacting short-term revenue but is expected to improve margins and long-term sustainability.
  • +SG&A expenses have increased significantly, outpacing revenue growth, which warrants further investigation into cost drivers.

Analysis Dimensions

Our 5-pass AI analysis examines this filing across multiple dimensions. Each dimension score is derived from direct analysis of SEC filing text.

Narrative Intelligence

3.0/10

Management tone is balanced with focus on transition from wholesale to direct-to-clinic sales strategy leading to higher expected gross margins.

Full analysis includes: tone changes vs prior quarter, margin driver breakdown, forward guidance analysis, strategic priorities.

Accounting Quality

4.0/10

Earnings quality shows moderate accounting practices.

Full analysis includes: reserve and allowance changes, non-recurring item analysis, stock-based compensation impact, disclosure concerns.

Hidden Liabilities

Off-balance sheet risk is low.

Full analysis includes: cloud and purchase commitments, VIE/SPE exposure, covenant compliance status, refinancing risk assessment.

Risk Landscape

2.0/10

Overall risk profile shows capital structure risk as primary concern.

Full analysis includes: 8 risk categories with severity, new vs escalated risks, management response assessment, risk trend analysis.

Segment Performance

2.0/10

Segment health analysis.

Full analysis includes: segment-by-segment revenue breakdown, geographic concentration risk, customer concentration analysis, segment margin trends.